Policies on Committees, Task Forces & Shared Interest Groups
As leaders in the collaborative research and innovation of Pain Medicine, AAPM is shaping the approach to pain-related care.
AAPM Policies on Committees
AAPM Policies on Task Forces
AAPM Policies on Shared Interest Groups (SIGs)
Additional Expectations Regarding Scope of Work
Committee, task force, and SIG participation is dependent on expectations for members as well as policy on what AAPM will provide to each group.
Member Roles and Responsibilities
- Each committee, task force, and SIG chair will submit a written report of its activities to the Board for the annual and mid-year board meetings.
- All committee, task force, and SIG activities must align with the overall mission of the Academy.
- All resources requested and activities proposed in the name of an AAPM committee, task force, or SIG will be submitted to the AAPM Board for approval prior to expenditure unless already included in the approved budget.
- The work of any committee, task force, or SIG shall be considered the work product of the Academy and may not be used in other ways without the Academy’s expressed written consent.
- No chemical or biological materials may be used in AAPM provided meeting space, unless previously specifically approved through headquarters staff.
AAPM Provisions
- AAPM will provide administrative support for each committee, task force and SIG, through a staff liaison. All committee, task force, and SIG communications will be distributed through staff liaisons.
- AAPM will provide meeting space during the Annual Meeting for each committee, task force, and SIG, upon request and as availability allows. However, committee, task force, and SIG meetings during the Annual Meeting are intended to be in-person meetings. Participation is limited to those physically in attendance. No teleconference arrangements will be provided for meetings held at the Annual Meeting.
- Committee, task force, and SIG emails and any files transmitted with it are confidential and intended solely for the use of the individual or entity to whom they are addressed. Unauthorized distribution beyond the original intended distribution list is prohibited.